Skip to content

By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.

Peter Attia MDPeter Attia MD

#110 – Lew Cantley, Ph.D.: Cancer metabolism, cancer therapies, and the discovery of PI3K

Sign up to receive Peter's email newsletter: https://bit.ly/4c602k2 Original release date: 5/11/20 In this episode, Lew Cantley, Professor of cancer biology and Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College in NYC, walks us through his amazing discovery of phosphoinositide 3-kinase (PI3K) and the implications for the care of patients with cancer. He explains various combinations of therapies being tested and used, including the possibility of pairing prescriptive nutritional therapies to increase the efficacy of drugs like PI3K inhibitors. Lew also explains the metabolic nature of cancer through the lens of his research into the connection between sugar consumption, insulin resistance, and tumor growth. Additionally, Lew provides some details about his exciting new clinical trial that is just now enrolling patients with stage 4 breast cancer and endometrial cancer. We discuss: -Teaching science through the lens of discovery—a better approach to learning science [5:15]; -The metabolic nature of cancer, mitochondria, and a more nuanced explanation of the Warburg Effect [8:30]; -The observation that convinced Lew to stop eating sugar [20:15]; -The connection between obesity, insulin resistance, and cancer [25:30]; -Sugar consumption and tumor growth—What did Lew’s 2019 paper find? [32:00]; -Natural sugar vs. HFCS, fruit vs. fruit juice, insulin response and cancer growth [43:00]; -Increasing efficacy of PI3K inhibitors with ketogenic diets, SGLT2 inhibitors, and metformin [53:30]; -Lew’s clinical trial enrolling stage 4 breast cancer and endometrial cancer patients [1:07:30]; -Pairing diet with drug could be the future of cancer treatment [1:09:30]; -PI3K inhibitors on the market, alpha vs. delta isoform, and the possibility of pairing them with a food prescription [1:16:15]; -What questions will Lew be focused on in the next chapter of his career? [1:22:15]; -Lew’s early work that ultimately led to the discovery of PI3K [1:27:30]; -Studying the mechanism by which mitochondria make ATP [1:30:45]; -How understanding the mechanism by which insulin drove glucose uptake into a cell got Lew closer to finding PI3K [1:38:15]; -How Lew knew PI3K was important in driving growth of cancer cells [1:55:00]; -Lew’s unlikely observation of phosphorylation at the 3′ position of the inositol ring resulting in the formation of phosphatidylinositol-3-phosphate [1:59:00]; and -More. Show notes page: https://peterattiamd.com/lewcantley/ -------- About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://peterattiamd.com Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle

Peter AttiahostLew Cantleyguest
Jul 8, 20202h 11mWatch on YouTube ↗

Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.

At a glance

WHAT IT’S REALLY ABOUT

Lew Cantley on Insulin, Sugar, PI3K Inhibitors, and Cancer Metabolism

  1. Cantley describes how insulin activates PI3K, the same enzyme many oncogenes use, which led him to conclude that insulin resistance and high insulin accelerate tumor growth.
  2. His lab found that mice drinking a sugary liquid containing both glucose and fructose grew larger colorectal polyps, because fructose reaches the colon and lowers ATP so glucose carbon is diverted into building tumor mass.
  3. PI3K alpha inhibitors cause hyperglycemia, and the resulting insulin surge can reactivate PI3K in tumors, so Cantley's team showed that lowering insulin with a ketogenic diet or SGLT2 inhibitor made the inhibitors work much better in mouse cancer models.
  4. Cantley and Attia discuss his companies Petra and Faeth, which aim to test an SGLT2 inhibitor plus PI3K inhibitor trial and to provide standardized meals as part of cancer therapy.
  5. In an appendix, Cantley recounts how an unexpected lipid-kinase activity, a one-millimeter shift on a thin-layer plate, and a mislabeled reagent led to discovering PI3K and its products.

IDEAS WORTH REMEMBERING

5 ideas

Unexpected results are where breakthroughs come from

Cantley says he gravitates to results that don't fit the simple explanation, and he urged his student to chase the surprising pyruvate kinase finding rather than dismiss it as boring.

The Warburg effect can reflect carbon diversion, not broken mitochondria

Cantley and colleagues proposed that cancer cells regulate glycolysis to divert intermediates into building lipids, serine, and nucleotides while mitochondria keep functioning.

Insulin, not just body weight, may be the key driver of cancer risk

Cantley cited a breast cancer study in which insulin-sensitive overweight women had no increased risk, while insulin-resistant women, including lean ones, did, and he argued BMI is a poor correlate.

Sugary liquids with glucose plus fructose can feed colorectal tumors directly

In mice given a small amount equal to a 12-ounce soda without obesity, polyps still grew two to three times larger because fructose reached the colon and phosphorylation by ketohexokinase drained ATP, letting glucose flood anabolic pathways.

PI3K inhibitors fight an insulin rebound

Alpha-isoform inhibitors raise glucose, prompting insulin release that reactivates PI3K, so Cantley insisted trial patients not be managed with insulin or insulin secretagogues, and about half could not be managed on metformin alone.

WORDS WORTH SAVING

5 quotes

Serendipity in science is absolutely critical that when you get a result that's unexpected, you should be laser-focused on understanding at the biochemistry, at the chemical level why you got the different result than you expected to get.

— Lew Cantley

If I get a result that suddenly doesn't make sense, to me that's more exciting. It means there's something more complicated going on than the simplest explanation for what I'm seeing.

— Lew Cantley

In order to try to always challenge people in my lab to prove me wrong rather than prove me right, and because it's always learned more if my simplest idea is wrong.

— Lew Cantley

Most endocrinologists worry about the glucose. I worry about the insulin.

— Lew Cantley

If we don't convert those observations into actual change in behavior or change in practice or change in drug metabolism and diet, then in the end we've failed.

— Lew Cantley

PI3K discovery and signalingInsulin resistance and cancer riskSugar, fructose, and colorectal cancer in miceWarburg effect and cancer metabolismPI3K inhibitors and hyperglycemiaKetogenic diets and SGLT2 inhibitors with cancer drugsDiet-drug pairing via Petra and Faeth

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.